Increased urge for movement, physical and mental restlessness, fundamental symptoms of restricting anorexia nervosa?


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
03 2020
Historique:
received: 12 10 2019
revised: 05 12 2019
accepted: 04 01 2020
pubmed: 6 2 2020
medline: 18 3 2021
entrez: 5 2 2020
Statut: ppublish

Résumé

Continued mobility in the presence of severe weight loss is a well known, yet insufficiently researched characteristic of anorexia nervosa (AN). This study was designed to assess the prevalence of the drive for activity, here operationalized as an increased urge for movement, physical restlessness, and mental restlessness. Participants were 83 female consecutively admitted adolescent patients qualifying for a diagnosis of AN (ICD-10), restricting subtype. Information collected included responses to a questionnaire inquiring retrospectively about physical and psychological reactions after significant weight loss (on average 12.5 kg) and to measures of psychiatric and eating disorder pathology and exercise behaviors at hospital admission. Over 80% of AN patients reported experiencing, at least partly, either, an increased urge for movement, physical or mental restlessness after significant weight loss. Altogether 95.1% reported, at least partly, one or a combination of two or all three symptoms. The sensations coexisted with equally high levels of fatigue and loss of energy, typically observed in starvation. The increased urge for movement and physical restlessness were foremost associated with reported actual physical activity and with weight loss. By contrast, mental restlessness was strongly linked to the degree of eating disorder pathology and to the severity of psychiatric symptoms. This is the first investigation of the presence of an increased urge for movement, physical restlessness, and mental restlessness after significant weight loss in patients with acute AN. The symptoms, given their high frequency and specificity, are likely pathogenic for AN and, if replicated, deserve to be considered for inclusion as diagnostic criteria for AN.

Identifiants

pubmed: 32017454
doi: 10.1002/brb3.1556
pmc: PMC7066368
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e01556

Informations de copyright

© 2020 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.

Références

Int J Eat Disord. 2015 Jan;48(1):42-5
pubmed: 24687461
Diabetologia. 2015 Aug;58(8):1751-8
pubmed: 26003325
Eat Behav. 2017 Jan;24:45-48
pubmed: 28011408
Psychoneuroendocrinology. 2004 Jul;29(6):791-7
pubmed: 15110928
Nat Genet. 2019 Aug;51(8):1207-1214
pubmed: 31308545
Front Psychol. 2018 Nov 23;9:2303
pubmed: 30532724
J Affect Disord. 2005 Apr;85(3):245-58
pubmed: 15780694
Eat Behav. 2007 Aug;8(3):334-49
pubmed: 17606231
J Behav Med. 1993 Dec;16(6):611-28
pubmed: 8126715
Am J Clin Nutr. 2005 Dec;82(6):1253-9
pubmed: 16332658
J Eat Disord. 2018 Jul 1;6:17
pubmed: 30002829
Compr Psychiatry. 1997 Nov-Dec;38(6):321-6
pubmed: 9406737
Int J Eat Disord. 2016 Aug;49(8):750-2
pubmed: 27315579
Eur Eat Disord Rev. 2011 May-Jun;19(3):256-68
pubmed: 21584918
Psychother Psychosom Med Psychol. 2011 Feb;61(2):82-6
pubmed: 21337286
Int J Eat Disord. 2015 Jan;48(1):46-54
pubmed: 25196139
Br J Psychiatry. 1973 Jan;122(566):83-5
pubmed: 4683028
J Eat Disord. 2018 Nov 28;6:42
pubmed: 30505444
J Intern Med. 2007 Sep;262(3):273-87
pubmed: 17697152
Biol Psychiatry. 2006 Aug 1;60(3):311-3
pubmed: 16376860
Brain Behav. 2020 Mar;10(3):e01556
pubmed: 32017454

Auteurs

Regina C Casper (RC)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.

Ulrich Voderholzer (U)

Schön Klinik Roseneck, Prien am Chiemsee, Germany.

Silke Naab (S)

Schön Klinik Roseneck, Prien am Chiemsee, Germany.

Sandra Schlegl (S)

Department of Psychiatry and Psychotherapy, University Hospital of Munich (LMU), Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH